FDA Approved: SODIUM PHENYLACETATE AND SODIUM BENZOATE — Original Application (Omnivium Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Omnivium's generic sodium phenylacetate and sodium benzoate (original application) for treatment of hyperammonemia due to urea cycle disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperammonemia
• Urea Cycle Disorder

Drugs mentioned

• Sodium phenylacetate and sodium benzoate (sodium phenylacetate and sodium benzoate)

Snippet

ORIG AP for SODIUM PHENYLACETATE AND SODIUM BENZOATE (SODIUM PHENYLACETATE AND SODIUM BENZOATE)